Clinical Alerts
April 25, 2025
Showing 1 - 10 of 23 results
Clinical Alerts
October 23, 2024
CDC Recommends Second Dose of 2024-2025 COVID-19 Vaccine for People 65 Years and Older and for People Who are Moderately or Severely Immunocompromised
Podcast
September 4, 2024
PALTtalk | Navigating Conversations and the Latest Science on COVID-19 Vaccine (Part 2 of 2)
In Episode 2 of our two-part series, host Elizabeth Sobczyk, MSW, MPH, and special guest Leslie Eber, MD, CMD, share practical strategies for clinicians to enhance conversations about the COVID-19 vaccine and highlight leadership actions that have successfully increased vaccination rates in PALTC. We also ...
Podcast
August 29, 2024
PALTtalk | The Practical Two-Part Series | Navigating Access and Billing Challenges for COVID-19 Vaccine (Part 1 of 2)
JAMDA
April 6, 2024
Engaging Long-Term Care Workers in Research: Recruitment Approaches and Participant Characteristics From a Randomized Controlled Trial to Improve COVID-19 Vaccine Confidence
To describe and compare the recruitment methods employed in a randomized controlled trial targeting long-term care workers, and resulting participant baseline characteristics.
Podcast
April 5, 2024
AMDA On-The-Go | Update on RSV Vaccines
Policy Snapshot
January 19, 2024
CMS, CDC to Hold Immunization Webinar on January 31
The Centers for Medicare & Medicaid Services (CMS) and the Centers for Disease Control and Prevention (CDC) will hold a webinar, CDC and CMS Present Stories from the Field: Immunization Strategies for Long-term Care, on Wednesday, January 31, from 2:00-3:00 PM ET.
Spotlight
August 30, 2023
Needles Are Moving, as Vaccination Project Enters Round Two
Moving Needles, a project to improve immunization rates among residents and staff in post-acute and long-term care, is doing just that—moving the needle on vaccination rates.
JAMDA
June 7, 2023
Association of Sources of COVID-19 Information with Vaccine Uptake, Preventive Behaviors, and Perceived Severity of COVID-19
To investigate the association of using informal sources and reliance on multiple sources of information with actual COVID-19 vaccine uptake, the number of doses of vaccine received, COVID-19 testing, essential preventive measures, and perceived severity of COVID-19.
JAMDA
April 21, 2023
Risk of Adverse Events and Delirium after COVID-19 Vaccination in Patients Living with Dementia
The aim of this study was to compare incidences of adverse events of special interest (AESI) and delirium in 3 cohorts: after COVID-19 vaccination, prepandemic, and SARS-CoV-2 polymerase chain reaction (PCR) test positive.
